| |
Aggregate Spend Solutions and Regulatory Compliance Products
Porzio Life Sciences’ regulatory compliance software solutions, products and services assist pharmaceutical, medical device and biotechnology companies in complying with marketing and sales regulations, including PDMA, anti-kickback statutes, False Claims Act, FDA, OIG, Physician Payments Sunshine Act, Affordable Care Act and state aggregate spend compliance regulations.
Porzio AggregateSpendID® is an automated web-based solution for spend and samples data capture, tracking and reporting. The system collects spend associated with sales representatives, senior executives, medical meetings, clinical trials, grants, eGrants, speaking fees, honoraria, etc.
Products and Services
Porzio AggregateSpendID®— Web-based system to track spend and samples directed towards healthcare providers and organizations - read more ►
|
News
Porzio celebrates its 3rd Annual National Customer Service Week! - Read more
AdvaMed is the world’s largest medical technology association representing manufacturers of medical devices, diagnostics products, and medical information systems - Read more
Christine Bradshaw and Sarah Canberg Quoted in Article on the Sunshine Act’s Complexity►
Christine N. Bradshaw, Associate of Porzio, Bromberg & Newman and Director of Regulatory and Compliance Services of Porzio Life Sciences, LLC and Sarah M. Canberg, Associate of Porzio, Bromberg & Newman and Manager of Regulatory and Compliance Services of Porzio Life Sciences, LLC are quoted in the Compliance Week article "Final Version Provides Little Relief for Complex Sunshine Act.” - Read more or go to Compliance Week►
Scott Liebman and Christine Bradshaw Quoted in Article on the Finalization of the Sunshine Act ►
Scott Liebman, Principal of Porzio, Bromberg & Newman and Vice President of Porzio Life Sciences and Christine Bradshaw, Associate of Porzio, Bromberg & Newman and Director of Regulatory and Compliance Services of Porzio Life Sciences are quoted in the article "The Sunshine Act is Finally Final" in the Pharma & Healthcare section of Forbes.com - Read more or go to Forbes
Elizabeth Kim & Kiaema Reid, Co-Authors of Compliance Manual ►
Porzio Life Sciences’s Elizabeth H. Kim, Manager of Regulatory and Compliance Services and Kiaema Reid, Senior Regulatory Analyst, are contributors to the composition of the “Pharmaceutical and Medical Device Compliance Manual,” - Read more
More News►
Careers
REGULATORY ASSISTANT, COMPLIANCE SERVICES ASSISTANT, QUALITY CONTROL SUPERVISOR and FINANCIAL SERVICES SPECIALIST openings at our Morristown office.
read more ►
|
Events
AdvaMed's Global MedTech Compliance Conference ►
Michelle Axelrod is speaking at and John Oroho is attending AdvaMed's 2014 Global MedTech Compliance Conference on May 20-22, 2014 in Barcelona, Spain. Michelle will moderate Parallel session 1: "Low Cost" Compliance: How can SMEs do it? Takes place on May 20-22, 2014 - Read more
International Pharmaceutical Compliance Congress and Best Practices Forum ►
Timothy Ayers, Christine Bradshaw and Brian Sharkey are speaking at the 8th Annual International Pharmaceutical Compliance Congress and Best Practices Forum in Dubai, United Arab Emirates. Takes place on May 5-7, 2014 - Read more
CBI's West Coast Medical Education & Research Grants Summit ►
Christine Bradshaw is a speaker at CBI's West Coast Medical Education & Research Grants Breakthrough Summit. Takes place on April 29-30, 2014 - Read more
CBI's Life Sciences Advisory Board Strategy and Efficiency Summit ►
Timothy Ayers is a speaker at CBI's Life Sciences Advisory Board Strategy and Efficiency Summit. Takes place on April 28-29, 2014 - Read more
CBI West Coast Transparency and Aggregate Spend ►
Timothy Ayers and John Oroho are speaking at the 5th Annual CBI West Coast Forum on Transparency & Aggregate Spend. Takes place on April 23-25, 2014 - Read more
ACI's 14th National Summit on Reducing Legal Risks in the Sales and Marketing of Medical Devices ►
Christine Bradshaw is a speaker at ACI's 14th National Summit on Reducing Legal Risks in the Sales and Marketing of Medical Devices: Strengthening Compliance Efforts in an Environment of Increased Government Scrutiny and New Reporting Requirements. Takes place on April 9-11, 2014 - Read more
4th CBI Global Transparency Reporting Congress ►
Jeffrey Campbell and Christine Bradshaw will be attending the 4th Annual CBI Global Transparency Reporting Congress. Takes place on April 8-9, 2014 - Read more
10th Annual Meeting of ISMPP ►
Audrey DeGuarde, Kiaema Reid, Jennifer Romanski and Brian Sharkey are speaking at the 10th Annual Meeting of ISMPP in Arlington, VA. Takes place on April 7-9, 2014 - Read more
American Conference Institute’s 14th National Pharmaceutical Compliance & Enforcement Forum ►
Christine Bradshaw spoke on the Sunshine Act Compliance Boot Camp: Preparing, Modifying, and Monitoring Data Collection and Reporting Systems on March 19-20, 2014 - Read more
The Pharmaceutical Compliance Forum Spring 2014 Meeting ►
Timothy Ayers spoke at the Pharmaceutical Compliance Forum Spring 2014 Members-Only Meeting on March 11, 2014 - Read more
More Events►
Articles
FDA’s Office of Prescription Drug Promotion (OPDP) Enforcement: A Summary of 2013 Warning and Untitled Letters ►
FDA’s Office of Prescription Drug Promotion (OPDP) issued a total of 24 enforcement letters to pharmaceutical manufacturers in 2013, 3 Warning Letters and 21 Untitled Letters - Read more
Getting the Deal Through: Life Sciences 2014 - United States Chapter Life Sciences in 24 Jurisdictions Worldwide ►
Article by John Patrick Oroho and Brian P. Sharkey - “In recent years, the United States has seen a significant increase in federal and state government-initiated enforcement actions against life sciences companies, many of which have resulted in multi-million, or even multi-billion, dollar settlements and penalties - Read more
Bloomberg BNA Pharmaceutical Law & Industry Report
Porzio Life Sciences, LLC
EFPIA Leads the Self-Regulation Charge to Try to Avoid Government-Imposed Transparency ►
The debate between government-imposed disclosure requirements and industry self-regulation supporters continues to heat up around the world. In this update, D. Jeffrey Campbell and Brian P. Sharkey discuss how the European Federation of Pharmaceutical Industries and Associations (EFPIA) is leading the movement toward self-regulation by its recent adoption of a new disclosure code - Read more
|
|